We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
(-4.4%)
Cap. Flow
+$802M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$78.7M |
| 2 |
XYZ
Block Inc
XYZ
|
+$49.3M |
| 3 |
Visa
V
|
+$46.1M |
| 4 |
Apple
AAPL
|
+$45.4M |
| 5 |
DoorDash
DASH
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$23.2M |
| 3 |
Williams-Sonoma
WSM
|
+$22.2M |
| 4 |
Broadcom
AVGO
|
+$20.3M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.67% |
| 2 | Financials | 14.43% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $25.1K | ﹤0.01% |
1,431
| – | – |
|
3327
Solarmax Technology
SMXT
$21.6M
| $24.9K | ﹤0.01% |
20,768
+7,360
| +55% | +$10.5K |
|
|
IGMS
3328
DELISTED
IGM Biosciences
IGMS
| $24.5K | ﹤0.01% |
21,331
-1,287
| -6% | -$2.39K |
|
|
MTLS
3329
Materialise
MTLS
$396M
| $23.8K | ﹤0.01% |
4,831
+378
| +8% | +$2.6K |
|
|
VNET
3330
VNET Group
VNET
$2.09B
| $23.6K | ﹤0.01% |
2,877
-6,454
| -69% | -$59.2K |
|
3331
Harvard Bioscience
HBIO
$29.2M
| $23.4K | ﹤0.01% |
4,140
+196
| +5% | +$2.51K |
|
3332
CAMP4 Therapeutics
CAMP
$266M
| $23.3K | ﹤0.01% |
5,820
-43,969
| -88% | -$213K |
|
|
LUCK
3333
Lucky Strike Entertainment
LUCK
$911M
| $23.1K | ﹤0.01% |
2,367
| – | – |
|
|
NBIS
3334
Nebius Group N.V.
NBIS
$47.7B
| $23K | ﹤0.01% |
1,090
-12,190
| -92% | -$401K |
|
3335
Skye Bioscience
SKYE
$18.3M
| $22.9K | ﹤0.01% |
14,423
-3,082
| -18% | -$8.41K |
|
|
MODV
3336
DELISTED
ModivCare
MODV
| $22.8K | ﹤0.01% |
17,371
-5,425
| -24% | -$26.2K |
|
3337
Oppenheimer Holdings
OPY
$1.2B
| $22.7K | ﹤0.01% |
380
| – | – |
|
|
CD
3338
Chaince Digital Holdings
CD
$211M
| $22.4K | ﹤0.01% |
4,174
-12,480
| -75% | -$79.5K |
|
|
CO
3339
DELISTED
Global Cord Blood Corporation
CO
| $22.3K | ﹤0.01% |
24,817
-19,940
| -45% | -$17.9K |
|
|
AMBR
3340
Amber International Holding Ltd
AMBR
$130M
| $22.3K | ﹤0.01% |
1,862
-417
| -18% | -$3.8K |
|
|
AISP
3341
Airship AI Holdings
AISP
$71.3M
| $21.6K | ﹤0.01% |
5,609
+2,569
| +85% | +$11.9K |
|
|
HHR
3342
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $21.5K | ﹤0.01% |
1,430
-2,295
| -62% | -$34.5K |
|
3343
MarketWise
MKTW
$56.6M
| $21.1K | ﹤0.01% |
2,136
+665
| +45% | +$7.96K |
|
3344
FibroBiologics
FBLG
$6.5M
| $21K | ﹤0.01% |
1,168
+89
| +8% | +$2.54K |
|
|
UHG
3345
DELISTED
United Homes Group
UHG
| $21K | ﹤0.01% |
7,502
-19,094
| -72% | -$73.9K |
|
3346
Metagenomi Therapeutics
MGX
$46.3M
| $20.9K | ﹤0.01% |
15,399
+3,401
| +28% | +$8.1K |
|
3347
374Water
SCWO
$37.6M
| $20.9K | ﹤0.01% |
6,144
+993
| +19% | +$4.39K |
|
3348
Century Therapeutics
IPSC
$361M
| $20.6K | ﹤0.01% |
43,273
+182
| +0.4% | +$137 |
|
|
ELEV
3349
DELISTED
Elevation Oncology
ELEV
| $20.4K | ﹤0.01% |
78,732
+8,697
| +12% | +$4.96K |
|
3350
Offerpad Solutions
OPAD
$23.1M
| $20.3K | ﹤0.01% |
1,223
+55
| +5% | +$1.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
- RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
- RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
- RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
- RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
- RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
- RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.
Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.